Ryan D. Morrison

2.4k citations

76 papers · 2.0k · h-index 27

Impact in

Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research
- Neuropeptides and Animal Physiology
Biological Psychiatry top 10%

Papers in

Cellular and Molecular Neuroscience 44
- Neuroscience and Neuropharmacology Research 42
- Neuropeptides and Animal Physiology 4
- Neurotransmitter Receptor Influence on Behavior 3
Molecular Biology 53
- Receptor Mechanisms and Signaling 32
- Pharmacological Receptor Mechanisms and Effects 14
- Ion channel regulation and function 11
- Nicotinic Acetylcholine Receptors Study 5

Co-authors: John Scott Daniels (58 shared papers)Craig W. Lindsley (49 shared papers)P. Jeffrey Conn (36 shared papers)Colleen Marie Niswender (36 shared papers)Carrie K. Jones (23 shared papers)Anna Louise Blobaum (20 shared papers)Frank W. Byers (15 shared papers)Thomas M. Bridges (15 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (22 papers)ACS Chemical Neuroscience (11 papers)Journal of Medicinal Chemistry (8 papers)Laboratory Investigation (3 papers)Drug Metabolism and Disposition (3 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Ryan D. Morrison

74 papers receiving 2.0k citations

Peers

Countries citing papers authored by Ryan D. Morrison

Since Specialization

Citations

This map shows the geographic impact of Ryan D. Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan D. Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan D. Morrison more than expected).

Fields of papers citing papers by Ryan D. Morrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan D. Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan D. Morrison. The network helps show where Ryan D. Morrison may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan D. Morrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan D. Morrison Line = papers co-authored together Ryan D. Morrison links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ML297 (VU0456810), the First Potent and Selective Activator of the GIRK Potassium Channel, Displays Antiepileptic Properties in Mice ACS Chemical Neuroscience ·Kristian W. Kaufmann, Ian M. Romaine, Emily Days, Conrado Pascual, Adam A. Malik, Liya Yang, Bende Zou, Yu Hui Du	2013	131
2	Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models Journal of Neuroscience ·Gregory J. Digby, Meredith J. Noetzel, Michael Bubser, Thomas J. Utley, Adam G. Walker, Nellie E. Byun, Evan P. Lebois, Zixiu Xiang	2012	95
3	The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease Journal of Pharmacology and Experimental Therapeutics ·Carrie K. Jones, Michael Bubser, Analisa D. Thompson, Jonathan W. Dickerson, N. Turle-Lorenzo, Marianne Amalric, Anna Louise Blobaum, Thomas M. Bridges	2011	92
4	Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model Neuropsychopharmacology ·Ayan Ghoshal, Jerri M. Rook, Jonathan W. Dickerson, G N Roop, Ryan D. Morrison, Nidhi Jalan‐Sakrikar, Atin Lamsal, Meredith J. Noetzel	2015	90
5	Metabolism and Distribution of Clozapine-N-oxide: Implications for Nonhuman Primate Chemogenetics ACS Chemical Neuroscience ·Jessica Raper, Ryan D. Morrison, John Scott Daniels, Leonard Lee Howell, Jocelyne Bachevalier, Thomas Wichmann, Adriana Galván	2017	86
6	The Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson’s Disease ACS Chemical Neuroscience ·Zixiu Xiang, Analisa D. Thompson, John T. Brogan, M. Schulte, Bruce J. Melancon, Debbie Mi, L. Michelle Lewis, Bende Zou	2011	84
7	Design, Synthesis, and Biological Evaluation of Halogenated N-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: Discovery of an Isoform-Selective Small Molecule Phospholipase D2 Inhibitor Journal of Medicinal Chemistry ·Robert R. Lavieri, Sarah Scott, Paige E. Selvy, Kwangho Kim, Satyawan B Jadhav, Ryan D. Morrison, John Scott Daniels, H. Alex Brown	2010	79
8	Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: Development of a highly selective and more potent in vitro probe Bioorganic & Medicinal Chemistry Letters ·Eric J. Delpire, Aleksandra Baranczak, Alex G. Waterson, Kwangho Kim, Nathan R. Kett, Ryan D. Morrison, John Scott Daniels, C. David Weaver	2012	71
9	Development of Dual PLD1/2 and PLD2 Selective Inhibitors from a Common 1,3,8-Triazaspiro[4.5]decane Core: Discovery of ML298 and ML299 That Decrease Invasive Migration in U87-MG Glioblastoma Cells Journal of Medicinal Chemistry ·Matthew C. O’Reilly, Sarah Scott, Kyle A. Brown, Thomas H. Oguin, Paul Glyndwr Thomas, John Scott Daniels, Ryan D. Morrison, H. Alex Brown	2013	63
10	Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents Journal of Medicinal Chemistry ·Julie L. Engers, Alice L. Rodriguez, Leah C. Konkol, Ryan D. Morrison, Analisa D. Thompson, Frank W. Byers, Anna Louise Blobaum, Sichen Chang	2015	60
11	Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) with Oral Efficacy in an Antiparkinsonian Animal Model Journal of Medicinal Chemistry ·Carrie K. Jones, Darren W. Engers, Analisa D. Thompson, Julie R. Field, Anna Louise Blobaum, Stacey R. Lindsley, Ya Zhou, Rocco D. Gogliotti	2011	55
12	Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu3 Selective and CNS Penetrant Negative Allosteric Modulator (NAM) Journal of Medicinal Chemistry ·Cody J. Wenthur, Ryan D. Morrison, Andrew S. Felts, Katrina A. Smith, Julie L. Engers, Frank W. Byers, John Scott Daniels, Kyle A. Emmitte	2013	50
13	Chemical Modulation of Mutant mGlu 1 Receptors Derived from Deleterious GRM1 Mutations Found in Schizophrenics ACS Chemical Biology ·Hyekyung P. Cho, Pedro M. García-Barrantes, John T. Brogan, Corey R. Hopkins, Colleen Marie Niswender, Alice L. Rodriguez, Daryl F. Venable, Ryan D. Morrison	2014	49
14	Discovery, Synthesis, and Preclinical Characterization ofN-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4) ACS Chemical Neuroscience ·Darren W. Engers, Anna Louise Blobaum, Rocco D. Gogliotti, Yiu‐Yin Cheung, James M. Salovich, Pedro M. García-Barrantes, John Scott Daniels, Ryan D. Morrison	2016	42
15	Biotransformation of a Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Contributes to Seizure-Like Adverse Events in Rats Involving a Receptor Agonism-Dependent Mechanism Drug Metabolism and Disposition ·Thomas M. Bridges, Jerri M. Rook, Meredith J. Noetzel, Ryan D. Morrison, Ya Zhou, Rocco D. Gogliotti, Paige N. Vinson, Zixiu Xiang	2013	42
16	Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects Neuropsychopharmacology ·Robert W. Gould, Russell Joseph Amato, Michael Bubser, Max E. Joffe, Michael T. Nedelcovych, Analisa D. Thompson, Hilary Highfield Nickols, Johannes P Yuh	2015	41
17	Design and Synthesis of N -Aryl Phenoxyethoxy Pyridinones as Highly Selective and CNS Penetrant mGlu 3 NAMs ACS Medicinal Chemistry Letters ·Julie L. Engers, Katrina A. Bollinger, Rebecca L. Weiner, Alice L. Rodriguez, Madeline F. Long, Megan M. Breiner, Sichen Chang, Sean R. Bollinger	2017	38
18	Targeting Selective Activation of M1 for the Treatment of Alzheimer’s Disease: Further Chemical Optimization and Pharmacological Characterization of the M1 Positive Allosteric Modulator ML169 ACS Chemical Neuroscience ·James Christopher Tarr, Mark Turlington, Paul R. Reid, Thomas J. Utley, Douglas J. Sheffler, Hyekyung P. Cho, Rebecca Klar, Tristano Pancani	2012	38
19	Discovery of ( S )-2-Cyclopentyl- N -((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1 H -pyrrido[3,4- b ]indole-4-carboxamide (VU0453379): A Novel, CNS Penetrant Glucagon-Like Peptide 1 Receptor (GLP-1R) Positive Allosteric Modulator (PAM) Journal of Medicinal Chemistry ·Lindsey C. Morris, Kellie D. Nance, Patrick R. Gentry, Emily Days, C. David Weaver, Colleen Marie Niswender, Analisa D. Thompson, Carrie K. Jones	2014	38
20	Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM Bioorganic & Medicinal Chemistry Letters ·Douglas J. Sheffler, Cody J. Wenthur, Joshua Andrew Bruner, Sheridan J. S. Carrington, Paige N. Vinson, Kiran K. Gogi, Anna Louise Blobaum, Ryan D. Morrison	2012	36

About Ryan D. Morrison

Ryan D. Morrison is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Family Practice, Toxicology and Oncology, having authored 76 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (42 papers), Receptor Mechanisms and Signaling (32 papers), Pharmacological Receptor Mechanisms and Effects (14 papers), Ion channel regulation and function (11 papers), Nicotinic Acetylcholine Receptors Study (5 papers), Cardiac electrophysiology and arrhythmias (4 papers), Neuropeptides and Animal Physiology (4 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.1k citations), Biological Psychiatry (54 citations), Molecular Biology (1.2k citations), Family Practice (19 citations) and Physiology (42 citations). Ryan D. Morrison has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include John Scott Daniels, Craig W. Lindsley, P. Jeffrey Conn, Colleen Marie Niswender, Carrie K. Jones, Anna Louise Blobaum, Frank W. Byers, Thomas M. Bridges, Kyle A. Emmitte and C. David Weaver. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Chemical Neuroscience, Journal of Medicinal Chemistry, Laboratory Investigation and Drug Metabolism and Disposition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Ryan D. Morrison

Impact in

Papers in i

In The Last Decade

Ryan D. Morrison

Peers

Countries citing papers authored by Ryan D. Morrison

Fields of papers citing papers by Ryan D. Morrison

All Works

About Ryan D. Morrison

Explore authors with similar magnitude of impact

Papers in